BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 23485503)

  • 1. Detailed analysis of patients with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institutional study.
    Kim IY; Modi PK; Sadimin E; Ha YS; Kim JH; Skarecky D; Cha DY; Wambi CO; Ou YC; Yuh B; Park S; Llukani E; Albala DM; Wilson T; Ahlering T; Badani K; Ahn H; Lee DI; May M; Kim WJ; Lee DH
    J Urol; 2013 Aug; 190(2):527-34. PubMed ID: 23485503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathologic implications of prostatic anterior fat pad.
    Jeong J; Choi EY; Kang DI; Ercolani M; Lee DH; Kim WJ; Kim IY
    Urol Oncol; 2013 Jan; 31(1):63-7. PubMed ID: 21396837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lymph Node Metastasis to the Prostatic Anterior Fat Pad in the Patients Treated with Prostatectomy].
    Shimizu Y; Ogawa K; Kida K; Tsuchihashi K; Kanamaru S; Ishihara M; Hashimoto K; Ito N
    Hinyokika Kiyo; 2018 Sep; 64(9):359-363. PubMed ID: 30369226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncologic outcomes in men with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institution international study.
    Kwon YS; Ha YS; Modi PK; Salmasi A; Parihar JS; Patel N; Faiena I; May M; Lee DI; Llukani E; Patrick T; Rha KH; Ahlering T; Skarecky D; Ahn H; Choi SK; Park S; Jeon SS; Ou YC; Eun D; Manucha V; Albala D; Badani K; Yuh B; Ruel N; Kim TH; Kwon TG; Marchalik D; Hwang J; Kim WJ; Kim IY
    BMC Urol; 2015 Aug; 15():79. PubMed ID: 26231860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The extent of pelvic lymph node dissection correlates with the biochemical recurrence rate in patients with intermediate- and high-risk prostate cancer.
    Schiavina R; Manferrari F; Garofalo M; Bertaccini A; Vagnoni V; Guidi M; Borghesi M; Baccos A; Morselli-Labate AM; Concetti S; Martorana G
    BJU Int; 2011 Oct; 108(8):1262-8. PubMed ID: 21446934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of regional lymph nodes in periprostatic fat following robot-assisted radical prostatectomy.
    Yuh B; Wu H; Ruel N; Wilson T
    BJU Int; 2012 Feb; 109(4):603-7. PubMed ID: 21851536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological analysis of lymph nodes in anterior prostatic fat excised at robot-assisted radical prostatectomy.
    Aning JJ; Thurairaja R; Gillatt DA; Koupparis AJ; Rowe EW; Oxley J
    J Clin Pathol; 2014 Sep; 67(9):787-91. PubMed ID: 24996431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of anterior prostatic fat pad dissection for extended lymphadenectomy in prostate cancer: a non-randomized study of 100 patients.
    Ozkan B; Tunc B; Coskuner ER; Saglican Y; Yalçın V
    Int Urol Nephrol; 2015 Jun; 47(6):959-64. PubMed ID: 25899767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy.
    Kroepfl D; Loewen H; Roggenbuck U; Musch M; Klevecka V
    BJU Int; 2006 May; 97(5):985-91. PubMed ID: 16643480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutions.
    Suardi N; Larcher A; Haese A; Ficarra V; Govorov A; Buffi NM; Walz J; Rocco B; Borghesi M; Steuber T; Pini G; Briganti A; Mottrie AM; Guazzoni G; Montorsi F; Pushkar D; Van Der Poel H;
    Eur Urol; 2014 Oct; 66(4):635-43. PubMed ID: 24411992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
    Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F
    Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
    Heidenreich A; Varga Z; Von Knobloch R
    J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy.
    Heidenreich A; Ohlmann CH; Polyakov S
    Eur Urol; 2007 Jul; 52(1):29-37. PubMed ID: 17448592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended vs standard lymph node dissection in robot-assisted radical prostatectomy for intermediate- or high-risk prostate cancer: a propensity-score-matching analysis.
    Kim KH; Lim SK; Kim HY; Shin TY; Lee JY; Choi YD; Chung BH; Hong SJ; Rha KH
    BJU Int; 2013 Jul; 112(2):216-23. PubMed ID: 23356436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Landscape and metastases of the lymph nodes in prostatic anterior fat pad at radical prostatectomy].
    Zhao DW; Zhou ZH; Zhao JL; Chen D; Yang ZY; Wang J; Long XB; Zhang YJ; Yang P; Cao Y; Li JB; Zhou FJ; Li YH
    Zhonghua Wai Ke Za Zhi; 2022 Nov; 60(11):999-1003. PubMed ID: 36323582
    [No Abstract]   [Full Text] [Related]  

  • 17. The impact of the extent of lymph-node dissection on biochemical relapse after radical prostatectomy in node-negative patients.
    Schiavina R; Bertaccini A; Franceschelli A; Manferrari F; Vagnoni V; Borghesi M; Morselli-Labate AM; Martorana G
    Anticancer Res; 2010 Jun; 30(6):2297-302. PubMed ID: 20651383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.
    Cagiannos I; Karakiewicz P; Eastham JA; Ohori M; Rabbani F; Gerigk C; Reuter V; Graefen M; Hammerer PG; Erbersdobler A; Huland H; Kupelian P; Klein E; Quinn DI; Henshall SM; Grygiel JJ; Sutherland RL; Stricker PD; Morash CG; Scardino PT; Kattan MW
    J Urol; 2003 Nov; 170(5):1798-803. PubMed ID: 14532779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancer.
    Abdollah F; Gandaglia G; Suardi N; Capitanio U; Salonia A; Nini A; Moschini M; Sun M; Karakiewicz PI; Shariat SF; Montorsi F; Briganti A
    Eur Urol; 2015 Feb; 67(2):212-9. PubMed ID: 24882672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardized comparison of robot-assisted limited and extended pelvic lymphadenectomy for prostate cancer.
    Yuh BE; Ruel NH; Mejia R; Novara G; Wilson TG
    BJU Int; 2013 Jul; 112(1):81-8. PubMed ID: 23351148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.